Transition metal doped hydrophilic ultrasmall iron oxide modulate MRI contrast performance for accurate diagnosis of orthotopic prostate cancer
Wenteng Xie,Yuehao Gan,Ya'nan Zhang,Peng Wang,Jia Zhang,Junchao Qian,Guilong Zhang,Zhengyan Wu
DOI: https://doi.org/10.1039/d2tb01860h
IF: 7.571
2022-10-26
Journal of Materials Chemistry B
Abstract:FDA-approved iron oxide nanocrystals (IONs) as negative magnetic resonance imaging contrast agents (MRI CAs) are encountering challenges because of its low relaxation rate and coherent ferromagnetism. Although the researches find that metal doping is an efficient approach to improve the magnetic property and MRI contrast performance of IONs, their systemic mechanism rarely involves. Herein, we fabricated a series of transition metal-doped IONs and systemically explored their sizes, structures, magnetic properties variation, revealing oxygen vacancy-mediated MRI contrast enhancement mechanism of transition metal-doped IONs. Based on these, we screen that Zn doped IONs possess the optimal T2 MRI contrast performance, and further investigate their potential to diagnose in vivo orthotopic tumor as T2 contrast agent. The results indicate that the use of Zn doped IONs significantly enhance T2-weighted MRI signal intensity of orthotopic prostate tumor with a low toxicity, which is beneficial to accurate diagnosis of orthotopic tumor. Collectively, this work clearly illustrates the mechanism of contrast enhancement of transition metal-doped IONs, and provides a novel paradigm for developing highly efficient T2 contrast agent.
materials science, biomaterials